Back to today’s briefing

Story perspectives

English Cancer Patients Struggle for Advanced Treatments

2/2/2026

26 3

Summary

Story summary

Cancer patients in England face a postcode lottery in accessing advanced treatments, according to doctors.
Doctors say stereotactic ablative body radiotherapy (SABR) and molecular radiotherapy (MRT) are underutilized due to bureaucratic hurdles and funding issues within the National Health Service (NHS).
SABR is effective for lung cancer, but its use for other cancers is limited, forcing some patients to seek treatment privately.

1 of 1

Story summary

Cancer patients in England face a postcode lottery in accessing advanced treatments, according to doctors.
Doctors say stereotactic ablative body radiotherapy (SABR) and molecular radiotherapy (MRT) are underutilized due to bureaucratic hurdles and funding issues within the National Health Service (NHS).
SABR is effective for lung cancer, but its use for other cancers is limited, forcing some patients to seek treatment privately.